Sustained efficacy of mepolizumab in patients with severe chronic rhinosinusitis with nasal polyps: SYNAPSE 24-week treatment-free follow-up

Sustained efficacy of mepolizumab in patients with severe chronic rhinosinusitis with nasal polyps: SYNAPSE 24-week treatment-free follow-up Article

publication date

July 18, 2023

webpage

Web of Science

published in

INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY Journal

keywords

biologic therapy
chronic rhinosinusitis with nasal polyps
durability
efficacy
mepolizumab
sinus surgery